Cancer-Associated Fibroblasts Genes and Transforming Growth Factor Beta Pathway in Gastric Cancer for Novel Therapeutic Strategy
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cancer-associated fibroblast genes (CAFGs) are key in gastric cancer (GC) progression. Understanding their roles and interactions with the TGF-beta pathway is vital for developing new GC therapies.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Cancer-associated fibroblasts (CAFs) significantly influence the gastric cancer (GC) tumor microenvironment.
- Identifying the molecular characteristics of CAFs-associated genes (CAFGs) is crucial for understanding their role in GC progression and patient prognosis.
Purpose Of The Study
- To review and summarize current knowledge on CAFGs in GC.
- To highlight CAFGs' expression patterns, prognostic significance, and potential functional mechanisms.
Main Methods
- Comprehensive literature review focusing on CAFGs in GC.
- Analysis of single-cell RNA sequencing (scRNA-seq) data to assess CAFGs expression in CAFs and pericytes.
- Review of clinicopathological studies validating the prognostic significance of CAFGs.
Main Results
- CAFGs expression is not exclusive to CAFs and can indicate surrounding cell activation.
- Several CAFGs (e.g., SPARC, THBS2, COL1A1, COL3A1, INHBA, PDGFC, SDC2) show prognostic relevance in GC.
- Functional mechanisms of these genes in GC are less understood compared to other cancers; synchronized expression with TGFB1 seen in colorectal cancer is not yet confirmed in GC.
Conclusions
- A thorough understanding of CAFGs and their interplay with the TGF-beta pathway, including LTBP genes, is essential for novel GC therapeutic strategies.
- Further research is required to fully elucidate the functional mechanisms and therapeutic potential of CAFGs in GC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...